As a part what seems like a sea of new compliance and regulation coming over the horizon, first to arrive in early 2018 will be the MiFID revision,
Case study: Morningside
About the client: For more than 20 years, Morningside Pharmaceuticals has provided a wide range of niche, high quality branded generic medicines and